deep dive 2020
deep dive 2020
Join Neudata — in partnership with Morgan Stanley — for a 90-minute Deep Dive event into the healthcare datasets that are proving most useful for asset managers in the wake of COVID-19.
Healthcare datasets enjoyed a spike of relevancy this year, as investors rushed to understand how best to track number of cases, the virus’ spread, and, eventually, the likelihood of viable vaccine. On 29th October, Neudata’s healthcare specialist will discuss where we’ve come from and where we’re going with a panel of leading buy-side and sell-side analysts, as well as healthcare data vendors.
This event is the fourth in a monthly series of thematic Deep Dives with Morgan Stanley.
Who should attend:
Public market investors
Venture capital investors
Private equity investors
Corporations using alternative data to influence strategy
Data and technology providers
12:00pm ET Welcome & Introduction – Dean Murphy, Neudata
12:05pm ET Inside the Mind of an Analyst (IMOA) – Healthcare Services and Technology – Ricky Goldwasser & Jasper Lin, Morgan Stanley
12:40pm ET Data Case Study – Andrew Robson, Earnest
12:50pm ET Data Case Study
1:00pm ET Using Alt Data to Diagnose the Impact of COVID-19 on Healthcare Stocks – Kathryn Forde, Neudata
1:30pm ET Close
Ricky Goldwasser is a Managing Director at Morgan Stanley who joined the firm in 2009 and covers the Healthcare Services and Technology industry. Prior to joining Morgan Stanley, Ricky was co-head of the US Healthcare research team at UBS, where she covered Healthcare Services, Diagnostics, and Generic companies. She started her research career as an associate at Salomon Smith Barney in 1998. Ricky has ranked in the Institutional Investor All America research team for over a decade. She holds an MBA degree from The Kellogg School of Management and a BA in Economics and Political Science from Tel-Aviv University.
Jasper Lin is a Sector Quant in Alphawise at Morgan Stanley Research. He is responsible for building models and analytics that combines fundamental perspective with quantitative insights from alternative data as well as traditional datasets. Prior to his current role. Jasper was a desk quant at Morgan Stanley Fixed Income Sales and Trading where he worked 3 years for the municipal securities desk and 2 years for the securitized product desk. He holds a PhD in physics from Columbia University and a BS from Peking University.
Dean is responsible for leading, developing and expanding Neudata’s events programme.
Having spent the last decade creating, building and scaling conference and content businesses within the FinTech and Energy sectors, Dean has worked with some of the most recognisable global brands on B2B events of all sizes. Dean co-founded two conference companies in 2013 and exited through acquisition in early 2020.
Dean holds a BA Hons degree in Theatre and Performance Studies from Warwick University.
Andrew Robson is President of Earnest Research. He joined Earnest after over ten years with Gerson Lehrman Group (GLG), the leading platform for professional expertise and insights. Andrew was a member of GLG’s executive team, most recently as Head of Business Development for the firm’s largest business unit. He held a variety of product, service, and business development leadership roles throughout his GLG tenure. He holds a MBA from Columbia Business School and a BS from Syracuse University.
Find out more about Neudata and keep up-to-date by signing up to our email newsletter.